Encantor Moves Closer to IDE Study After EFS Results at NY Valves

Research evidence excerpt

Encantor Moves Closer to IDE Study After EFS Results at NY Valves

TD Cowen Abbott Laboratories

Global Research June 29, 2026

physicians have adequate time to perform rotational adjustments before committing to

complete valve expansion.

Only after satisfactory alignment is achieved does the operator continue the motorized

deployment sequence. The presenter emphasized that this controlled expansion improves

procedural stability while potentially reducing operator variability and improving implantation

consistency.

In early experience (FIH + EFS), operators reported active commissural alignment, precise

deployment depth, minimal foreshortening, and large outflow cells for coronary access.

Notably, ABT appears to be targeting traditional limitations associated with the balloon-

expandable design (alignment and commissural control) while attempting to preserve

precision - suggesting the company will position Encantor as a device boasting the benefits of

both balloon-expandable deployment accuracy and self-expandable alignment capability.

AI-Enabled Procedural Planning and Real-Time Deployment Control

The presenter repeatedly emphasized Encantor's digital environment as one of the platform's

most important differentiators. The tablet-based interface provides real-time procedural

information, incorporating patient-specific sizing data and balloon inflation parameters into a

single operator display. Rather than relying on fixed inflation volumes, physicians can modify

balloon filling during the procedure while immediately visualizing how additional balloon

volume alters the effective expansion applied to the patient's anatomy.

For example, incremental increases in balloon volume can be selected directly on the tablet,